Amylyx Pharmaceuticals Inc (AMLX)
Operating Cash Flow (Statement)
-$126.58M
TTM · Period ending: · USD
AMLX Operating Cash Flow (Statement)
Latest reported-$126.58Mperiod ending
Latest reported-$126.58Mperiod ending
AMLX Cash from Operations (-$10.69M → -$126.58M)
Annual operating cash flow (statement)
High-resolution chart · PNG
AMLX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -123,343,000 | |
| -167,647,000 | |
| 11,919,000 | |
| -179,871,000 | |
| -74,799,000 | |
| -36,697,000 | |
| -10,687,000 |